Hashemian H, Mirshahi R, Khodaparast M, et al. Post-cataract surgery endophthalmitis: brief literature review. J Curr Ophthalmol. 2016;28:101–5.
Article PubMed PubMed Central Google Scholar
Jabbarvand M, Hashemian H, Khodaparast M, et al. Retraction notice to: endophthalmitis occurring after cataract surgery: outcomes of more than 480 000 cataract surgeries, epidemiologic features, and risk factors. Ophthalmology. 2016;123:295–301.
Packer M, Chang DF, Dewey SH, et al. Prevention, diagnosis, and management of acute postoperative bacterial endophthalmitis. J Cataract Refract Surg. 2011;37:1699–714.
Shi SL, Yu XN, Cui YL, et al. Incidence of endophthalmitis after phacoemulsification cataract surgery: a meta-analysis. Int J Ophthalmol. 2022;15:327–35.
Article PubMed PubMed Central Google Scholar
Zafar S, Dun C, Srikumaran D, et al. Endophthalmitis rates among medicare beneficiaries undergoing cataract surgery between 2011 and 2019. Ophthalmology. 2022;129:250–7.
Hou CH, Lee JS, Lin KK, et al. Risk and dose–response relationship of diabetes mellitus for endophthalmitis after cataract surgery in a nationwide cohort study in Taiwan. Clin Exp Ophthalmol. 2023;51:692–703.
Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmology. 2002;109:13–24.
Behndig A, Cochener B, Güell JL, et al. Endophthalmitis prophylaxis in cataract surgery: overview of current practice patterns in 9 European countries. J Cataract Refract Surg. 2013;39:1421–31.
Escrs Endophthalmitis Study Group. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007;33:978–88.
Han DC, Chee SP. Survey of practice preference pattern in antibiotic prophylaxis against endophthalmitis after cataract surgery in Singapore. Int Ophthalmol. 2012;32:127–34.
Chang DF, Rhee DJ. Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2021 ASCRS member survey. J Cataract Refract Surg. 2022;48:3–7.
Çakır B, Celik E, Aksoy NÖ, et al. Toxic anterior segment syndrome after uncomplicated cataract surgery possibly associated with intracamaral use of cefuroxime. Clin Ophthalmol. 2015;9:493–7.
Article PubMed PubMed Central Google Scholar
Das T, Joseph J, Simunovic M, et al. Consensus and controversies in the science of endophthalmitis management: basic research and clinical perspectives. Prog Retin Eye Res. 2023;97:101218.
Sherman RE, Anderson SA, Dal Pan GJ, et al. Real-world evidence—what is it and what can it tell us. N Engl J Med. 2016;375:2293–7.
Najafzadeh M, Schneeweiss S. From trial to target populations—calibrating real-world data. N Engl J Med. 2017;376:1203–5.
Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: A tutorial. Int J Epidemiol. 2017;46:348–55.
Gower EW, Lindsley K, Tulenko SE, et al. Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery. Cochrane Database Syst Rev. 2017;2:CD006364.
Hsieh CY, Su CC, Shao SC, et al. Taiwan’s national health insurance research database: past and future. Clin Epidemiol. 2019;11:349–58.
Article PubMed PubMed Central Google Scholar
Wu CS, Lai MS, Gau SSF, et al. Concordance between patient self-reports and claims data on clinical diagnoses, medication use, and health system utilization in Taiwan. PLoS ONE. 2014;9:e112257.
Article PubMed PubMed Central Google Scholar
National Health Insurance Administration, Ministry of Health and Welfare, Taiwan. Payment code inquiry for diagnosis, procedure, and medication. https://info.nhi.gov.tw/INAE5000/INAE5001S01. Accessed 28 Oct 2024.
Ng J, Morlet N, Clark A. Anterior vitrectomy at the time of cataract surgery: a whole-population study of the incidence and consequences. Invest Ophthalmol Vis Sci. 2013;54:893–893.
Charlson ME, Carrozzino D, Guidi J, et al. Charlson comorbidity index: a critical review of clinimetric properties. Psychother Psychosom. 2022;91:8–35.
D’hoore W, Sicotte C, Tilquin C. Risk adjustment in outcome assessment: the Charlson comorbidity index. Methods Inf Med. 1993;32:382–7.
Xu S, Ross C, Raebel MA, et al. Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals. Value Health. 2010;13:273–7.
Mccaffrey DF, Griffin BA, Almirall D, et al. A tutorial on propensity score estimation for multiple treatments using generalized boosted models. Stat Med. 2013;32:3388–414.
Article PubMed PubMed Central Google Scholar
Austin PC. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat Simul Comput. 2009;38:1228–34.
Division of Cancer Control and Population Sciences, National Cancer Institute. How joinpoint selects the final model. https://surveillance.cancer.gov/help/joinpoint/setting-parameters/method-and-parameters-tab/model-selection-method. Accessed 04 Dec 2024.
Wagner AK, Soumerai SB, Zhang F, et al. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27:299–309.
Article CAS PubMed Google Scholar
Hu Y, Van Lenthe FJ, Hoffmann R, et al. Assessing the impact of natural policy experiments on socioeconomic inequalities in health: How to apply commonly used quantitative analytical methods? BMC Med Res Methodol. 2017;17:68.
Article PubMed PubMed Central Google Scholar
Schober P, Boer C, Schwarte LA. Correlation coefficients: appropriate use and interpretation. Anesth Analg. 2018;126:1763–8.
Chang DF, Braga-Mele R, Henderson BA, et al. Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2014 ASCRS member survey. J Cataract Refract Surg. 2015;41:1300–5.
Haripriya A. Antibiotic prophylaxis in cataract surger: an evidence-based approach. Indian J Ophthalmol. 2017;65:1390–5.
Article PubMed PubMed Central Google Scholar
Chang DF, Braga-Mele R, Mamalis N, et al. Prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2007 ASCRS member survey. J Cataract Refract Surg. 2007;33:1801–5.
Keating GM. Levofloxacin 0.5% ophthalmic solution. Drugs. 2009;69:1267–86.
Article CAS PubMed Google Scholar
Drlica K. Mechanism of fluoroquinolone action. Curr Opin Microbiol. 1999;2:504–8.
Article CAS PubMed Google Scholar
Kim SY, Lim JA, Choi JS, et al. Comparison of antibiotic effect & corneal epithelial toxicity between levofloxacin 0.5% (Cravit®) & moxifloxacin 0.5% (Vigamox®) in vitro. Invest Ophthalmol Vis Sci. 2006;47:3565–3565.
Han KE, Chung WS, Kim TI, et al. Epithelial wound healing after cataract surgery comparing two different topical fluoroquinolones. Yonsei Med J. 2014;55:197–202.
Article CAS PubMed Google Scholar
Edwar L, Bisara BB, Setiabudi R, et al. Safety of intracameral injection of levofloxacin 0.5% eye drops single dose 0.6 ml preservative free on rabbit eye. F1000Res. 2023;12:772.
留言 (0)